{"id":"W2134829539","doi":"10.1016/s1474-4422(08)70117-0","title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1563,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Institute on Aging; National Institute of Neurological Disorders and Stroke; Medical Research Council; National Institutes of Health; Fondazione Grigioni per il Morbo di Parkinson; Agence Nationale de la Recherche; Volkswagen Foundation; Brain Research Trust; Mayo Clinic; Parkinson's UK; Michael J. Fox Foundation for Parkinson's Research","keywords":"LRRK2; Penetrance; Disease; Dyskinesia; Mutation; Medicine; Genotype; Parkinson's disease; Internal medicine; Mutation frequency; Genetics; Phenotype; Biology; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02268382312665334,"score_gpt":0.2559868105886196,"score_spread":0.2333029874619662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}